Mukka Proteins Presents Q4 & FY26 Investor Presentation
Mukka Proteins Limited released its Q4 & FY26 Investor Presentation. For FY26, Total Income was ₹1,478.20 crore, and Profit was ₹57.10 crore. Revenue from operations reached ₹1,449.5 crore. The company is expanding into Sri Lanka and Oman, and secured a waste management contract. It projects revenues to exceed ₹3,000 crore by FY30.
The investor presentation provides an update on financial performance and strategic direction, including future growth projections and expansion plans. This information is material for investors assessing the company's prospects.
The announcement of an investor presentation, coupled with positive financial performance highlights and strategic expansion plans, indicates a positive outlook for the company.
Mukka Proteins Limited has released an Investor Presentation detailing its financial results for the fourth quarter and full fiscal year 2026. The presentation covers the company's performance, business updates, and strategic outlook.
The company highlights its transformation from a fishmeal manufacturer to an integrated animal protein and sustainability platform, with core businesses in Fish Protein, Insect Protein, Waste Management, and Frozen Seafood. Mukka Proteins holds a significant market share of 25-30% in the Indian fishmeal and fish oil sector and exports to over 25 countries. The company has received confirmation from Global Trust Certification (NSF), Ireland for its alignment with the MarinTrust Improver Programme, underscoring its commitment to responsible sourcing and sustainability.
Key financial highlights for FY26 include a Total Income of ₹1,478.20 crore and Profit for the year of ₹57.10 crore. For Q4 FY26, Total Income stood at ₹1,021.50 crore, with a Profit for the year of ₹48.10 crore. The company also reported significant growth in revenue from operations, reaching ₹1,449.5 crore in FY26, up from ₹980.00 crore in FY25. EBITDA for FY26 was ₹57.1 crore, with a margin of 3.9%, and PAT was ₹57.1 crore with a margin of 3.9%.
Strategic initiatives include the expansion of its Oman facility, which is currently underway, and a new manufacturing and trading operation in Sri Lanka. Mukka Proteins has also secured a contract from BBMP/BSWML for integrated animal waste management in Bengaluru. The company anticipates strong multi-year growth, projecting revenues to exceed ₹3,000 crore by FY30. Mukka Proteins is also focusing on innovation, backward integration, and manufacturing excellence, with a stated goal of doubling revenue in approximately four years.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.